Sputnik V vaccine 13% less effective against Delta than originally reported

pharmafile | August 11, 2021 | News story | Medical Communications, Research and Development  

Russian health officials have announced that the Sputnik V COVID vaccine is 83% effective against the Delta variant on Wednesday, 13% lower than originally reported in June.

Alexander Gintsburg, director of the Gamaleya Institute which developed the vaccine, said in an interview with the Izvestia newspaper that Sputnik V was safe and effective against all strains of the coronavirus.

Russia, which has a population of around 144 million, has approved four domestically produced vaccines. It has recorded almost 6.5 million infections since the start of the pandemic.

On Wednesday Russia reported 799 coronavirus-related deaths, an all time high and the fourth time this month a new death record has been made.

Authorities have blamed the surge in cases on the Delta variant, which is more infectious, and the population’s reluctance to get vaccinated despite shots being widely available.

The Russian coronavirus task force also confirmed 21,571 new COVID-19 cases in the last 24 hours, a daily total that is declining gradually after peaking in July. It has confirmed a total of 6,512,859 cases and a death toll of 167,241.

The federal statistics agency has kept a separate death toll and has said that Russia recorded around 315,000 deaths related to COVID-19 from April 2020 to June 2021.

On Wednesday the Russian Direct Investment Fund released real world data on the efficacy of the vaccine on the anniversary of its registration.

The data was obtained during mass vaccinations in Argentina, Bahrain, Hungary, Mexico, Russia, Serbia, the Philippines and UAE, and showed a low number of severe adverse events.

Kat Jenkins

Related Content

No items found

Latest content